Key1 Capital

Activity from announced rounds

Activity in this selectionUndisclosed

Key1 Capital is an Israeli growth-technology manager whose investment records identify Lyte, Remepy and Xsight.

Recorded funding activity

Lyte develops robotic perception systems. Remepy combines prescription medicines with therapeutic software, while Xsight designs connectivity chips for computing infrastructure. The companies pursue distinct hardware and healthcare products.

Sources
Rounds participated in
1
Confirmed lead rounds
—
1 roles undisclosed
New companies
1
First participation on record · 0 follow-on
Funding in participating rounds
$107M
1 disclosed · full round size, not this investor’s share

By stage

Undisclosed1

By primary sector

AI1

By country

United States1

Rounds

1 in this selection
Lyte

Lyte develops perception systems for robots and autonomous machines used in inspection, logistics and manufacturing.

$107MUndisclosed
Role not disclosed